Intrathecal baclofen for treating spasticity in children with cerebral palsy
Editorial Group: Cochrane Movement Disorders Group
Published Online: 26 JAN 2004
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Hasnat MJ, Rice JE, O'Donnell ME. Intrathecal baclofen for treating spasticity in children with cerebral palsy (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004552. DOI: 10.1002/14651858.CD004552.
- Publication Status: Edited (no change to conclusions)
- Published Online: 26 JAN 2004
This is the protocol for a review and there is no abstract. The objectives are as follows:
1.To determine the effectiveness of intrathecal baclofen in treating spasticity in children with cerebral palsy.
2.To identify the range of outcome measures used in the evaluation of ITB and to determine what other measures are needed.
3.To determine whether ITB reduces the need for subsequent orthopaedic surgery in children with spasticity.
4.To determine the safety of ITB therapy
5.To consider the economic implications of the therapy